ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,319.31
2.30%
US Tech 100
18,006.00
3.54%
다우존스 지수
39,446.49
1.76%
Bitcoin
60,903.77
-1.35%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Cerevel Therapeutics Holdings Inc (CERE)

  7. Cerevel Therapeutics Holdings Inc (CERE) 뉴스

CERE

Cerevel Therapeutics (CERE)

Cerevel Therapeutics Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CERE
일자시간출처헤드라인심볼기업
2024/08/0613:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0613:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0613:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0605:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0605:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0605:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0605:30Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0605:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0605:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0605:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0122:33Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0122:32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0122:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0122:26Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0122:25Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0122:24Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0121:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/08/0121:23PR Newswire (US)AbbVie Completes Acquisition of Cerevel TherapeuticsNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/05/0905:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CERECerevel Therapeutics Holdings Inc
2024/04/1819:30GlobeNewswire Inc.Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s DiseaseNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/02/2806:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CERECerevel Therapeutics Holdings Inc
2024/02/1706:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/02/0923:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/02/0909:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/01/2422:30PR Newswire (US)Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law FirmNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/01/2407:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/01/2407:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/01/2407:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/01/2407:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
2024/01/2407:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
 검색 관련기사 보기:NASDAQ:CERE

최근 히스토리

NYSE
MRK
Merck
AMEX
XLF
Financial Select Sector
CCOM
US500
US 500
AMEX
XLE
Energy Select Sector SPDR
SPI
SP500
S&P 500
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
AAPL
Apple
AMEX
SPY
SPDR S&P 500
NYSE
CVX
Chevron
FX
USDEUR
US Dollar vs Euro
NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
MSFT
Microsoft
FX
USDGBP
US Dollar vs Sterling
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유